DURATION OF IMMUNITY OF LIVE VACCINE CEVAC S.
|
|
- Austen Greer
- 6 years ago
- Views:
Transcription
1 DURATION OF IMMUNITY OF LIVE VACCINE CEVAC S. Gallinarum TESTED BY Salmonella Enteritidis AND Salmonella Gallinarum CHALLENGES, 11 WEEKS AFTER VACCINATION József Herczeg1, Ágnes Makai1, Imre Héjja1, Éva Balla1, Gábor Szőnyi1, László Makranszki1, László Fodor2, Jérôme Thevenon1, Rick vanoort3 1CEVA-Phylaxia, Budapest, Hungary; 2Szent István University, Faculty of Vet. Sci., Dep. of Microbiology and Infectious Diseases, 3CEVA-Libourne, France
2 EFFICACY OF CEVAC CORYMUNE 4+7 K USED AS BOOSTER VACCINE AGAINST INFECTIOUS CORYZA, Salmonella Enteritidis AND Salmonella Gallinarum József Herczeg1, Ágnes Makai1, Imre Héjja1, Éva Balla1, Gábor Szőnyi1, László Makranszki1, László Fodor2, Jérôme Thevenon1, Rick vanoort3 1CEVA-Phylaxia, Budapest, Hungary; 2Szent István University, Faculty of Vet. Sci., Dep. of Microbiology and Infectious Diseases, 3CEVA-Libourne, France
3 EFFICACY OF CEVAC CORYMUNE 7 K USED AS BOOSTER VACCINE AGAINST NEWCASTLE DISEASE, INFECTIOUS BRONCHITIS AND EGG DROP SYNDROME József Herczeg1, Ágnes Makai1, Imre Héjja1, Éva Balla1, Gábor Szőnyi1, László Makranszki1, László Fodor2, Jérôme Thevenon1, Rick vanoort3 1CEVA-Phylaxia, Budapest, Hungary; 2Szent István University, Faculty of Vet. Sci., Dep. of Microbiology and Infectious Diseases, 3CEVA-Libourne, France
4 LABORATORY EFFICACY TESTING OF SUBCUTANEOUSLY ADMINISTERED CEVAC TRANSMUNE VACCINE IN BROILER CHICKENS József Herczeg1, Miklós Nagy1, László Makranszki1, Éva Balla1, Jean defoucauld1, Jérôme Thevenon1, Branko Alva2 1CEVA-Phylaxia, Budapest, Hungary; 2CEVA-Libourne, France
5 ONSET OF IMMUNITY OF LIVE VACCINE CEVAC S. Gallinarum TESTED BY Salmonella Enteritidis AND Salmonella Gallinarum CHALLENGES, 3 WEEKS AFTER VACCINATION József Herczeg1, Ágnes Makai1, Imre Héjja1, Éva Balla1, Gábor Szőnyi1, László Makranszki1, László Fodor2, Jérôme Thevenon1, Rick vanoort3 1CEVA-Phylaxia, Budapest, Hungary; 2Szent István University, Faculty of Vet. Sci., Dep. of Microbiology and Infectious Diseases, 3CEVA-Libourne, France
6 Salmonella Gallinarum EFFICACY OF CEVAC S. Gallinarum VACCINE BOOSTED WITH CEVAC CORYMUNE 4 K AND CEVAC CORYMUNE 7 K VACCINES, TESTED BY CHALLENGES AT 21 AND 35 WEEKS OF AGE József Herczeg1, Ágnes Makai1, Imre Héjja1, Éva Balla1, Gábor Szőnyi1, László Makranszki1, László Fodor2, Jérôme Thevenon1, Rick vanoort3 1CEVA-Phylaxia, Budapest, Hungary; 2Szent István University, Faculty of Vet. Sci., Dep. of Microbiology and Infectious Diseases, 3CEVA-Libourne, France
7
8
9
10 COMPARISON OF NEWCASTLE DISEASE POWDER VACCINES WITH LIQUID VACCINES IN BROILERS CONSIDERING THE HUMORAL RESPONSE AND VACCINAL REACTION K. Huyge1, et al 1Laboratory of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium 2Department of Farm Animal Health, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands 3Animal Health Service GD, Deventer, the Netherlands
11 The efficiency of spray vaccination methods is severely decreased by: the evaporation of airborne vaccine droplets of the generated aerosols, the wide droplet size distributions, affecting the deposition pattern of the vaccine particles causing adverse direct (respiratory distress and mortality) and indirect (mortality, growth retardation and increased susceptibility to colibacillosis) vaccinal reactions
12 Advantages of dry powder vaccines : inactivation by evaporation does not occur as powder vaccines are not subjected to physical state transitions, production of dry powder aerosols with narrow particle size distributions would enable targeting of specific areas of the respiratory tract (upper respiratory tract for primary vaccinations and upper, and lower respiratory tract for booster vaccinations) thereby avoiding the occurrence of vaccinal reactions.
13 haemagglutination inhibition (HI) antibodies against ND virus induced by powder vaccines did not differ significantly from those obtained with current liquid ND vaccines. powder vaccines were further improved by further narrowing particle size distributions and reducing virus loss during production and storage (unpublished data). Finally, in an in vivo experiment the humoral response and vaccinal reaction of powder vaccines was compared to that of current liquid ND vaccines, which is documented here.
14 Dropret size and Sero-response of SPF-broiler hens exposed to powder and liquid aerosols of live Newcastle disease vaccines at 4 days old (Log2 HI ND titre ± SD) Fine ND powder vaccine: 6.3 ± 0.3µm, 4.4 ± 1.0 Coarse ND powder vaccine: 33.3 ± 0.9µm, 3.4 ± 1.3 Coarse/fine ND powder vaccine (9:1): 37.0 ± 0.5µm, 4.3 ± 1.2 Coarse ND vaccine spray: 10.0 ± 0.25µm, 3.2 ± 1.1 Fine ND vaccine aerosol: ± 20.7µm, 5.2 ± 0.9
15 Discussion Although less virus inactivation occurred in the powder vaccines during dispersion, no significant differences were found between them and the corresponding current liquid vaccines regarding the humoral response. The fine liquid ND vaccine aerosol induced the highest HI titers despite the fact that here the largest virus inactivation occurred due to evaporation, resulting in much lower virus concentrations per m3 air than the fine powder vaccine.
16 COMBINED ADMINISTRATION OF NEWCASTLE DISEASE AND AVIAN METAPNEUMOVIRUS LIVE VACCINES TO ONE-DAY- OLD TURKEYS: VACCINE INTERACTION AND PROTECTION AGAINST VIRULENT AMPV Caterina Lupini1*, et al 1Dipartimento di Scienze Mediche Veterinarie, Alma Mater Studiorum University of Bologna, Ozzano Emilia (BO), Italy; 2Dipartimento di Sanita Pubblica, Patologia Comparata e Igiene Veterinaria, University of Padua, Legnaro (PD), Italy; 3Istituto Zooprofilattico Sperimentale delle Venezie, Legnaro (PD), Italy p685
17 Inroduction Vaccination against Newcastle disease (ND) is compulsory in Italy (6) and turkeys are also frequently vaccinated against Turkey Rinotracheitis (TRT, Avian Metapneumovirus (AMPV). Live vaccines administered during the first days of life with at least an interval of 7 days between the vaccinations, so as to avoid possible interference between the vaccines. A vaccination programme including a simultaneous administration of both vaccines in the hatchery would have several practical, economic and biosecurity advantages. Such a modification requires a study about the vaccines compatibility.
18 Treatment groups TRT group (16 birds) vaccinated with strain AMPV subtype B VCO3; B1 group (8 birds) vaccinated with strain NDV B1; VG/GA group (8 birds) vaccinated with strain NDV VG/GA; TRT+B1 group (16 birds) vaccinated with strains AMPV subtype B VCO3 and NDV B1, coadministered; TRT+VG/GA group (16 birds) vaccinated with strains AMPV subtype B VCO3 and NDV VG/GA, co-administered; CONTROL group (16 birds) treated with sterile water.
19 Sampling Oropharyngeal swabs were collected at 2, 4, 6, 8, 10, 14, 18, 22, 26 and 30 days p.v. to investigate the colonization and replication of vaccine viruses in target tissues by reverse transcriptase (RT-PCR). Blood samples were obtained at 7, 14, 21 and 28 days p.v. for detection of antibodies anti-ampv by IDEXX ELISA,
20 Challenge At day 21 p.v. eight animals from groups TRT, TRT+B1, TRT+VG/GA and Control were moved to other isolation units and challenged with virulent AMPV subtype B strain IT/Ty/Vr240/87. Each bird received by eyedrop 3.77 log10 CD50. From day 1 post-infection (p.i.) until the end of the trail, birds were monitored daily for clinical signs assigning a score to each bird, following the method described by Naylor and Jones (5).
21 RT-PCR results on vaccine take Number of positive birds/day of sampling to the RT- PCR for NDV were comparable in all vaccinated groups. All the animals shed at least once 4 days p.v. and the number of positive birds /group decreases significantly after 10 days p.v. The total number of positive birds to RT-PCR for AMPV differs only slightly among the three vaccinated groups. All animals shed at least once on 14th day p.v.
22 Serology No statistically significant difference (p> 0.05) between antibody titers of the AMPV vaccinated group and the control group until day 21 post-vaccination was found. At 28 days post-vaccination the mean antibody titers appears to be statistically higher in groups vaccinated in combination when compared to the Control group and the TRT group. The mean NDV-HI titers did not show significant differences between groups until day 21 (p> 0,05) (Figure 3). At day 28 the control group and the vaccinated groups differed significantly (p<0,05). Not statistically differences were observed between groups that received single or in-combination vaccines for bothvaccinal trains.
23 Challenge results After challenge with field AMPV strain, unvaccinated and challenged birds showed clinical signs with a mean score of 15.25, significantly higher than in all vaccinated groups. No statistically significant difference in clinical scores was found between the groups vaccinated in single or in combination.
24 In conclusion, It appears that concurrent vaccination of one-day old commercial turkeys with AMPV VCO3 vaccine strain and NDV B1 or VG/GA vaccine strains gives the same protection after AMPV challenge. Furthermore the AMPV vaccine given alone do not interfere with vaccines replication in the respiratory tract.
25 EFFECT OF CHALLENGE WITH 3 VIRULENT NEWCASTLE DISEASE VIRUSES ON EGG PRODUCTION IN VACCINATED WHITE LEGHORN LAYING HENS. Ruben Merino1, et al Departamento de Medicina y Zootecnia de Aves, FMVZ, UNAM. Mexico, DF, 04510, Mexico Merial Mexico SA de CV, El Marques, Queretaro, 76246, Mexico p701
26 Introduction Outbreaks of ND in birds older than 4 weeks old can be seen in two forms: respiratory distress is common in well protected flocks, with low mortality and digestive or nervous symptoms (1-2%), the diagnosis can be difficult. The classic form of ND is seen in flock with non-uniform immunity, so, nervous and digestive signs are common as well as drop in egg production and mortality rate higher than 5%
27 Vaccination program Age (w) Groups A B C vaccine 1 IB / ND ConnMass/La Sota strain ConnMass/La Sota ConnMass/La Sota 3 ND LaSota LaSota LaSota 5 ND+IB Coryza 127 5HpABC LaSota/Mass HpABC LaSota/Mass41 5 ND LaSota LaSota LaSota 46 IB - ND ConnMass/La Sota ConnMass/La Sota 10 ND P2005 P2005 Ulster 127 5HpABC LaSota/Mass41 ConnMass/La Sota 15 ND+IB+EDS Coryza 127 5HpABC LaSota/Mass HpABC LaSota/Mass41 15 ND P2005 Ulster 15 ND LaSota LaSota
28 Challenges 25 hens from groups A, B and C where challenged with Chimalhuacan, Torreon or Mx14 viruses, at 25 weeks old, by the ocular route with 106 EID50% / 0.2 ml After challenge, all groups were observed for 4 weeks. Samples for virus isolation were taken from 3 hens at 2 and 4 weeks post challenge. Virulent standard challenge strain Chimalhuacan, as well as Torreon strain (responsible for the major outbreak occurred in Northern Mexico in 2000) and a contemporary strain isolated in 2008 (Mx14 strain) where used for challenge.
29 Challenge results Egg production was above 90% at challenge, for all groups. The mean egg production in the 4 weeks after challenge period was lower in A group than in B and C groups. Egg quality was better (P<0.05) in groups B and C when compared with group A, regardless of challenge strain. Mortality was higher in group A than in the others, but only statistically significant in the challenge with Chimalhuacan and Mx14 NDv strains. All hens from group A showed clinical sings, and they were more severe than those observed in the other groups, independent of the challenge strain.
30 Serology The geometric mean of the titer in group A (HI titre at 24w: 38) was significantly lower (P<0.05) than in groups B and C (HI titre at 25W: 1702 and 2426), at the laying hens reception and previous to challenge. After challenge, there was not statistical difference among groups, independent of the challenge strain.
31 EFFICACY OF SEVERAL VACCINATION PROGRAMSin day-old pullets (Lohmann breed) AGAINST NEWCASTLE DISEASE CHALLENGE. Satra, J.1, et al 1Veterinary Biologics Assay Division, Bureau of Quality Control of Livestock Products, Department of Livestock Development Pakchong, Nakhonratchasima Thailand 2Ceva Animal Health Asia Pacific, p909
32 Introduction The association of live and inactivated ND vaccines in ayd-old-chicks has been extensively investigated and the results show that the HI titers, protection against challenge and persistence of immunity are better achieved when the combination of live and inactivated vaccines is used, compared to live or inactivated alone The benefit of the combination of live and killed vaccine in the hatchery is particularly clear in a context of strong viral pressure as it strengthens and prolongs the protection by combining the local immunity provided by live attenuated vaccine with humoral immunity (circulating antibodies) conferred by inactivated vaccines.
33 Treatment groups Group A: Vector HVT-NDV vaccine by SC injection (0.2 ml per chick) Group B: Live apathogenic enteric strain ND vaccine by eye drop (ED) route (0.03 ml per chick); Group C: Live apathogenic enteric strain (ED) + Vector HVT-NDV vaccine (SC); Group D: Live apathogenic enteric strain (ED) + Inactivated ND vaccine3 (SC, 0.1 ml per chick). Group E: Positive Control (unvaccinated but challenged with virulent NDV) Group F: Negative Control (un-vaccinatedand unchallenged)
34 Challenge The reference Thai NDV challenge strain (Lopburi strain ICPI 1.86) was used as a challenge virus for the groups A, B, C, D and E. The challenge was carried out by intramuscular application at a dosage of 5log10 EID50 per chick. Day-old chicks from group F were not challenged to serve as unvaccinated and unchallenged controls (negative controls). The chicks were kept in isolators, observed during 14 days and clinical signs and mortality recorded.
35 Serology samplings At day of age, before the beginning of the trial, 20 surplus birds were bled and the level of the maternally derived antibodies was assessed by HI test and a commercial Elisa test kit. At 14, 21 and 28 days post-vaccination, 20 birds per group were sampled and the sera were also tested using both HI and Elisa test. Finally, 14 days after each challenge, blood samples were taken from each of the survivors in all groups.
36 Challenge results Birds challenged at 14 days post-vaccination: All groups showed a very good level of protection varying between 90-95% and without any major differences among them. This is probably due to a high residual amount of maternal immunity.
37 Challenge results Birds challenged at 21 days post-vaccination: At three weeks after vaccination, some differences among the vaccination programs start to be noticed. The unvaccinated control group still showed 70% and this result was very similar to the one obtained by the group B, which was vaccinated only with a live apathogenic enteric strain. The groups A, C and D showed a very high level of protection, particularly the group A which achieved 100% of protection.
38 Challenge results Birds challenged at 28 days post-vaccination: At four weeks post-vaccination, the protection rate of the unvaccinated group was only 10%. The group vaccinated with only the live apathogenic enteric strain (group B) achieved 55% while groups A, C and D had very high levels of protection. Only the groups vaccinated with vector HVT-NDV reached 100% of protection Serology: look at the abstract
39 EFFICACY OF A RECOMBINANT NEWCASTLE DISEASE VACCINE (VECTORMUNE HVT NDV) BASED ON CLINICAL PROTECTION AND SHEDDING OF CHALLENGE VIRUS IN BROILER CHICKENS V. Palya1*, I. Kiss1, T. Tatar-Kis1, T. Mato1, B. Felfoldi1, Y. Gardin2 1Ceva-Phylaxia Co. Ltd., Szallas u. 5., 1107 Budapest, Hungary 2CEVA, Libourne, France p757
Vectormune ND a step towards control of Newcastle Disease
Poultry Vaccinology Summit April 28-30, Budapest, Hungary Vectormune ND a step towards control of Newcastle Disease Yannick Gardin 1, Vilmos Palya 1, John Elattrache 1, Marcelo Paniago 2, Christophe Cazaban
More informationWPSA & WVPA Scientific Conference Roberto Soares, DVM, MAM, ACPV Regional Technical Manager - Poultry Ceva Animal Health APAC Malaysia
WPSA & WVPA Scientific Conference 2013 Roberto Soares, DVM, MAM, ACPV Regional Technical Manager - Poultry Ceva Animal Health APAC Malaysia Outlook the presentation Major changes in the Asia Poultry Industry
More informationESSENTIAL PROTECTION
ESSENTIAL PROTECTION for better life BROILER ND K VITABRON L VITAPEST L NEW L Supported by C H I C K P R O G R A M CONVENTIONAL vaccine range against Newcastle Disease CEVA HATCHERY I MMUNIZATION CONTROL
More informationRECOMBINANT VACCINES Live or Killed
Antigens and Vaccines Molecular biology drives Innovation Antigen Gene of Interest Recombination RECOMBINANT VACCINES Live or Killed Antigens and Vaccines Molecular biology drives Innovation Antigen Gene
More informationCeva s offer to optimize performance Simpler vaccination and better safety
Ceva s offer to optimize performance Simpler vaccination and better safety Rick van Oort Poultry Corporate Range Manager Layer range CEVA Sante Animale Bangkok-Thailand March 12, 2013 Bodyweight (g) 1600
More informationDr.Christophe Cazaban
Dr.Christophe Cazaban Technical Manager Biology Innovation Strategy Department. Ceva Sante Animale, France Graduated from the French Veterinary University of Lyon in 1993 He completed his education with
More informationCevaC Mass L THe Ceva Mass solution
CevaC Mass L THe Ceva Mass solution Ceva Santé Animale S.A. - 10, av. de la Ballastière - BP 126-33500 Libourne Cedex - France Tel : + 33 5 57 55 40 40 - Fax : + 33 5 57 55 41 92 www.ceva.com CEVAC MASS
More informationTRUSTWORTHY POULTRY CEVAC CORYMUNE RANGE. Unique combination vaccines to protect against Coryza and Salmonella. Supported by CEVAC CORYMUNE 4K
CEVAC CORYMUNE RANGE Unique combination vaccines to protect against Coryza and Salmonella TRUSTWORTHY POULTRY CEVAC CORYMUNE RANGE Supported by CEVAC CORYMUNE 4K Unique broad combination vaccine against
More informationVector Newcastle vaccine usage in Latin America. Luiz Sesti, Technical Services Latin America Ceva, Brazil
Vector Newcastle vaccine usage in Latin America. Luiz Sesti, Technical Services Latin America Ceva, Brazil Countries with endemic velogenic Newcastle Disease (ND) in Latin America Mexico Guatemala Belize
More informationCEVAC CEVAC BROILER ND K / 5000 doses
CEVAC BROILER ND K / 5 doses CEVAC BROILER ND K Newcastle disease a permanent threat Newcastle Disease is highly contagious and exists in a wide range of forms. It is one of the four major poultry diseases
More informationInvestigation on the possible application of a serological DIVA monitoring strategy when a rhvt-h5 vaccine is used to control Avian Influenza
AVMA AAAP Convention 2016 August 7, San Antonio, Texas, USA Investigation on the possible application of a serological DIVA monitoring strategy when a rhvt-h5 vaccine is used to control Avian Influenza
More informationThe Review of Newcastle Disease Live Vaccines Application. By: M. Abdoshah
The Review of Newcastle Disease Live Vaccines Application By: M. Abdoshah Introduction Only one serotype (PMV1) Maternally derived antibodies are protective All vaccines are efficacious Is vaccine protection
More informationMG and MS Control in Layers
MG and MS Control in Layers Bernie Beckman, DVM Hy-Line International Hy-Line International Genetic Excellence Respiratory Diseases of Poultry Bacterial Diseases M. gallisepticum M. synoviae Coryza - Avibacterium
More informationASEAN STANDARDS FOR ANIMAL VACCINES
Adopted at the 40 th AMAF 11 October 2018 Ha Noi, Viet Nam ASEAN Cooperation in Food, Agriculture and Forestry ASEAN STANDARDS FOR ANIMAL VACCINES Third Edition Li v e s t o c k Publication Series No.2A
More informationGumboro Disease: where are we with IBDV epidemiology. J.J. (Sjaak) de Wit, DVM, PhD, dipl ECPVS GD Deventer, The Netherlands
Gumboro Disease: where are we with IBDV epidemiology J.J. (Sjaak) de Wit, DVM, PhD, dipl ECPVS GD Deventer, The Netherlands Gumboro-virus (IBDV) Avibirna-virus: 2 segments of dsrna Non enveloped virus
More informationSCIENTIFIC DISCUSSION EMEA/V/C/036. Intervet International B.V., Wim de Körverstraat 35, 5831 AN Boxmeer, The Netherlands. N/a
SCIENTIFIC DISCUSSION Product name: Nobilis IB 4-91 Procedure No.: EMEA/V/C/036 Applicant company : Active substances and strengths: (ATCvet code) Proposed International Non-proprietary Name: Intervet
More informationPoultry Disease Manual Characteristics And
Poultry Disease Manual Characteristics And Control Of Infections Written by: Dr. Jacquie Jacob, University of Kentucky Pullorum disease, also called Infection by Salmonella pullorum has also been reported
More informationBiological monitoring of vaccine take and productive parameters in broilers vaccinated with
Biological monitoring of vaccine take and productive parameters in broilers vaccinated with immune complex and recombinant vector vaccines against Infectious Bursal Disease (IBD) Luiz SESTI 1, Carlos Kneipp
More informationYOU THINK INFLUENZA IS FATAL? THINK AGAIN.
YOU THINK INFLUENZA IS FATAL? THINK AGAIN. HVT vector vaccine for H5 Avian Influenza protection Avian influenza Avian influenza remains a major threat for the global poultry industry. Among the different
More informationGumboro symposium 19 th & 20th of January 2012 BUDAPEST. Dr Sylvain COMTE Head of Poultry Franchise Poultry Corporate Marketing Director FRANCE
Ceva s Vision in poultry vaccination Gumboro symposium 19 th & 20th of January 2012 BUDAPEST Dr Sylvain COMTE Head of Poultry Franchise Poultry Corporate Marketing Director FRANCE Yann Arthus Bertrand
More informationPATHOLOGICAL AND IMMUNOLOGICAL STUDY OF AN IN OVO COMPLEX VACCINE AGAINST INFECTIOUS BURSAL DISEASE
Acta Veterinaha Hungahca 48 (4), pp. 443-454 (2000) PATHOLOGICAL AND IMMUNOLOGICAL STUDY OF AN IN OVO COMPLEX VACCINE AGAINST INFECTIOUS BURSAL DISEASE Maria KELEMEN'*, KatalinFORGACH 1, JuditlVAN 2, V.
More informationSummary of Product Characteristics
Health Products Regulatory Authority Summary of Product Characteristics 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Novamune concentrate and solvent for suspension for injection for chickens 2 QUALITATIVE
More informationProtection in specific-pathogen-free chickens with live avian metapneumovirus and Newcastle disease virus vaccines applied singly or in combination
Protection in specific-pathogen-free chickens with live avian metapneumovirus and Newcastle disease virus vaccines applied singly or in combination K Ganapathy, W J Cox, Dick Gough, P Cargill, Enrique
More informationDirector Biology Innovation Strategy Department. Ceva Sante Animale, France
Dr.Yannick Gardin Director Biology Innovation Strategy Department. Ceva Sante Animale, France Graduated as a Doctor in Veterinary Medicine, from Veterinary School of Lyon France 1977 : Join Ceva as Technical
More informationThe humoral immune responses to IBV proteins.
The humoral immune responses to IBV proteins. E. Dan Heller and Rosa Meir The Hebrew University of Jerusalem, Israel COST FA1207 meeting WG2 + WG3, Budapest, Jan. 2015 1 IBV encodes four major structural
More informationMonitoring for Mycoplasma
Monitoring for Mycoplasma in vaccinated and non-vaccinated Poultry flocks Dr. Bart van Leerdam, PhD Prevention and Control Tactics of Mycoplasma spp. in Poultry 1. Maintaining flocks free of Mycoplasma
More informationAn outbreak of a respiratory infection of multi-agents occurred in poultry flocks in Tripoli, Libya
An outbreak of a respiratory infection of multi-agents occurred in poultry flocks in Tripoli, Libya S.O. Al-GARIB*, A. A. ASHEG, A. KAMMON and M.A. HAMID Department of Poultry Disease, Faculty of Veterinary
More informationControl of Gumboro Disease
Control of Gumboro Disease using an Immune-Complex IBD Vaccine Branko Alva DVM, Poultry Specialist Global Product Manager Controlling Poultry Diseases NON RESIDENT DISEASES Newcastle Diseases Avian Influenza
More informationSCIENTIFIC DISCUSSION
SCIENTIFIC DISCUSSION 1. SUMMARY OF THE DOSSIER Nobilis Influenza H5N2 emulsion for injection, is an adjuvanted, inactivated vaccine against avian influenza type A, subtype H5 in chickens. Avian influenza
More informationmaking LT protection safer and easier
making LT protection safer and easier 1 vaccine up to 3 immunities 4 Vectormune FP-LT and. Vectormune FP-LT is a genetically engineered live fowl pox virus vaccine carrying 2 immunorelevant genes from
More informationANSES. Agence Nationale du Médicament Vétérinaire (National Agency for Veterinary Drugs) (Reference Member State) BP FOUGERES CEDEX FRANCE
ANSES Agence Nationale du Médicament Vétérinaire (National Agency for Veterinary Drugs) (Reference Member State) BP 90203 35302 FOUGERES CEDEX FRANCE DECENTRALISED PROCEDURE PUBLICLY AVAILABLE ASSESSMENT
More informationVaccination to stop transmission
Vaccination to stop transmission Arjan Stegeman j.a.stegeman@uu.nl Faculty of Veterinary Medicine Goals of vaccination To prevent clinical disease (production, animal welfare, treatment costs, antimicrobial
More informationEtiology. Paramyxovirus type 1 = Newcastle disease.
Newcastle Disease Many strains of similar virus cause signs ranging from mild respiratory signs (pneumotropic) with low mortality to severe neurological (neurotropic) and/or visceral lesions (viscerotropic)
More informationManaging Salmonella Risk. Carl Heeder, DVM
Managing Salmonella Risk Carl Heeder, DVM 1 Overview Levels of Disease Risk Management Disease Risk Equation Flock Immunity Exposure Risk Salmonella Challenge Data Salmonella enteriditis Salmonella heidelberg
More informationMolecular diagnosis of infectious bronchitis: recent developments. Richard Currie
Molecular diagnosis of infectious bronchitis: recent developments Richard Currie The infectious bronchitis virus RNA (nucleic acid) on the inside the genetic finger print Proteins (S1 and S2 spike proteins)
More informationSuggestions to prevent / control Respiratory Disease Complex in poultry
Suggestions to prevent / control Respiratory Disease Complex in poultry Dr. J. L. Vegad Adviser Phoenix Group 201/15, Gorakhpur, Jabalpur - 482001 Introduction Today, respiratory disease complex has emerged
More informationinvesting our GLOBAL RESOURCES FUTURE of in the POULTRY We ll be thereṭm
investing our GLOBAL RESOURCES in the FUTURE of POULTRY We ll be thereṭm 2 As the world has become interconnected, the need for a global perspective to animal health has never been more important. An outbreak
More informationISSN: (Print) (Online) Journal homepage:
Veterinary Quarterly ISSN: 01652176 (Print) 18755941 (Online) Journal homepage: https://www.tandfonline.com/loi/tveq20 Comparison of the effect of live Newcastle disease vaccine Clone 30 in broilers administered
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
[Version 8, 10/2012] Cevac MD HVT_2016-October-18 ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Cevac MD HVT suspension and solvent for suspension for injection
More informationhttp://www.ibs.upm.edu.my Challenges in controlling viral diseases of poultry Abdul Rahman Omar Institute of Bioscience Faculty of Veterinary Medicine Universiti Putra Malaysia aro@upm.edu.my Outline of
More informationIs Newcastle disease still a threat for the poultry industry?
Is Newcastle disease still a threat for the poultry industry? Marcelo PANIAGO Director Global Veterinary Services - Poultry Ceva Santé Animale Libourne - France Newcastle Disease in the world Newcastle
More informationWorldwide perspective on Infectious Bronchitis. Ruth Bouwstra, DVM, PhD Turkey February 2017
Worldwide perspective on Infectious Bronchitis Ruth Bouwstra, DVM, PhD Turkey February 2017 Infectious bronchitis virus Corona Virus, a ssrna virus - Relatively high rate of mutations (0,0012 subst per
More information«Together we are building a new reference to create value beyond animal health»
Ceva in key figures... Sales 2010: 468 million (v 2009 395 million) Annualgrowth: 18.5% - R&D expenditure: 9% of sales Number of employees: 2543 Present: 40 countries - R&D centers 11 - Production sites
More informationCorrelation of humoral and cellular immune responses induced by different IBV vaccination regime with the protection afforded against IBV Q1
Correlation of humoral and cellular immune responses induced by different IBV vaccination regime with the protection afforded against IBV Q1 Rajesh Chhabra 1,2, Anne Forrester 1,Stephane Lemiere 3, Julian
More informationInterpretation and Application of Results Manual
Interpretation and Application of Results Manual Contents Applications of Results Obtained from BioChek ELISA kits page 3 Good sampling and Sample Size page 4-8 Interpretation of BioChek Results page 9
More informationEvaluation of Two Vaccination Schemes Using Live Vaccines against Newcastle Disease in Chickens
Turk. J. Vet. Anim. Sci. 2007; 31(3): 165-169 TÜB TAK Research Article Evaluation of Two Vaccination Schemes Using Live Vaccines against Newcastle Disease in Chickens Mansur-ud-Din AHMAD 1, *, Mamoona
More informationEVALUATION OF DIFFERENT ROUTES OF VACCINATION BY CLONE VACCINE ON HUMORAL ANTIBODY RESPONSE
Explor Anim Med Res, Vol.7, Issue - 2, 2017, p. 165-169 Research Article EVALUATION OF DIFFERENT ROUTES OF VACCINATION BY CLONE VACCINE ON HUMORAL ANTIBODY RESPONSE Moin Khodayari, Adel Feizi * Received
More informationEvaluation of an effervescent tablet presentation of a live attenuated Newcastle Disease vaccine in laboratory and field conditions
Evaluation of an effervescent tablet presentation of a live attenuated Newcastle Disease vaccine in laboratory and field conditions Andrea Delvecchio 1, Thomas Delquigny 1, Jean-Bernard Herin 1, Jean-Claude
More informationLaboratory Clinical Study
V. Perez et al. Merial Avian Bulletin 3 (2008) Page 3 to 7 Laboratory Clinical Study Anatomopathological analysis of lymphoid organs and serological analysis of chickens vaccinated with a turkey Herpesvirus
More informationOptimization for Chick Performance Bangkok, Thailand 12 th March 2013
Optimization for Chick Performance Bangkok, Thailand 12 th March 2013 Marcelo PANIAGO, DVM, MSc, MBA Director Global Veterinary Services - Poultry Ceva Santé Animale Libourne - France Evolution of the
More informationG. W. WOOD J. C. MUSKETT and D. H. THORNTON MAFF, Central Veterinary Laboratory, New Haw, Weybridge, Surrey, U.K.
J. Comp. Path. 1986 vol. 96 OBSERVATIONS ON THE ABILITY OF AVIAN REOVIRUS VACCINMATION OF HENS TO PROTECT THEIR PROGENY AGAINST THE EFFECTS OF CHALLENGE WITH HOMOLOGOUS AND HETEROLOGOUS STRAINS By G. W.
More informationAdvances in Marek s Disease Vaccine Development:
Advances in Marek s Disease Vaccine Development: Michel Bublot, DVM, PhD - Merial R&D Asian Avian Forum 2016, Tokyo, July 12-13 Marek s Disease Control Good flock management Cleaning, disinfection Adequate
More informationField experience with vaccination in turkeys in Morocco. Taoufik RAWI M.C.I Santé Animale (Morocco)
Field experience with vaccination in turkeys in Morocco Taoufik RAWI M.C.I Santé Animale (Morocco) Field experience with vaccination in turkeys in Morocco Taoufik Rawi, DVM, MBA Head Of Technical Support
More informationPress Pack. Ceva launches VECTORMUNE AI, a novel technology vaccine for H5 Avian Influenza protection
Press Pack Ceva launches VECTORMUNE AI, a novel technology vaccine for H5 Avian Influenza protection Content 1) Summary 2) Definition of the vaccine 3) Safety 4) Efficacy 5) Additional advantages 6) Vectormune
More informationGeneral context and objectives of the project. Public private partnership (PPP) in Veterinary Public Health. EVADOC project Bangladesh Jan-June 2015
Modeling the effectiveness of avian influenza vaccination strategies in Bangladesh: evaluation of the added value of day old chick vaccination in hatcheries General context and objectives of the project
More informationImplications and implementation of dayold chick vaccination
Implications and implementation of dayold chick vaccination FAO technical meeting Beijing, 3 December 2013 Sophie von Dobschuetz On behalf of the meeting participants 1 Meeting background and objectives
More informationENCEFAL-VAC SUMMARY OF PRODUCT CHARACTERISTICS
ENCEFAL-VAC SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT ENCEFAL-VAC Live lyophilised vaccine for chickens 2. QUALITATIVE AND QUANTITATIVE
More informationHome News Chickens Turkeys Processing Other Poultry Regions Even
Page 1 of 5 Home News Chickens Turkeys Processing Other Poultry Regions Even Search Newsletter You are here: Home» Early detection for effective broody control» Early detection for effective broody control»
More informationCommercial chicken vaccination: part 1 spray and aerosol usage
Vet Times The website for the veterinary profession https://www.vettimes.co.uk Commercial chicken vaccination: part 1 spray and aerosol usage Author : William Garton Categories : General, Vets Date : April
More informationImmunogenicity and Safety of Queensland V4 and Ulster 2C strains of. Newcastle Disease Virus Given to Maternally Immune, Newly Hatched
1 Running title: Queensland V4 and Ulster 2C vaccination by nebulisation 2 3 4 5 6 Immunogenicity and Safety of Queensland V4 and Ulster 2C strains of Newcastle Disease Virus Given to Maternally Immune,
More informationVaccines of today and products needed for the short-, intermediate- and longterm. OIE/FAO OFFLU Conference Beijing China December 4-6, 2013
Vaccines of today and products needed for the short-, intermediate- and longterm XU, Wei-Cheng OIE/FAO OFFLU Conference Beijing China December 4-6, 2013 1 Influenza A reservoir & transmission H3N8, (H5N1)
More informationComparative immunogenicity of fowl cholera vaccine in Jinding ducks
The Bangladesh Veterinarian (2013) 30(2) : 41-45 Comparative immunogenicity of fowl cholera vaccine in Jinding ducks S Sultana, S Saha and MM Amin* 1 Department of Microbiology and Hygiene, Faculty of
More informationLaboratory Diagnosis of Avian Influenza and Newcastle Disease
Laboratory Diagnosis of Avian Influenza and Newcastle Disease Dennis A. Senne dennis.a.senne@aphis.usda.gov (515) 239-7551 U. S. Department of Agriculture, Animal and Plant Health Inspection Service, Veterinary
More informationGraduated from Kyoto University, Graduate School of Agriculture, Japan M.S degree on Molecular Biology and Microbiology.
Dr.Moto Esaki Senior Chief Reseacher Ceva Japan K.K Graduated from Kyoto University, Graduate School of Agriculture, Japan M.S degree on Molecular Biology and Microbiology. 1999 : Joined Biology department
More informationDRY POWDER VACCINES FOR MASS VACCINATION OF POULTRY
Ghent University Faculty of Pharmaceutical Sciences DRY POWDER VACCINES FOR MASS VACCINATION OF POULTRY NEW FORMULATIONS, COMPARISON WITH LIQUID VACCINES AND FEASIBILITY TO DECREASE ADVERSE VACCINAL REACTIONS
More informationEFFICACY OF AVIAN INFLUENZA VIRUS LOCALLY MANUFACTURED AND IMPORTED VACCINES ABSTRACT
Shaukat et al., The Journal of Animal & Plant Sciences, 26(3): 2016, Page: J. 653-657 Anim. Plant Sci. 26(3):2016 ISSN: 1018-7081 EFFICACY OF AVIAN INFLUENZA VIRUS LOCALLY MANUFACTURED AND IMPORTED VACCINES
More informationResearch note. Merial S.A.S., 29 avenue Tony Garnier Lyon cedex 07 France 2
Research note Monitoring of vaccine take by quantitative realtime polymerase chain reaction following different Marek s disease vaccination programs in future broiler breeders Delvecchio A. 1, Gimeno I.
More informationDepartment of Veterinary Pathology, University of Liverpool, Leahurst Campus, Neston, South Wirral, CH64 7TE, UNITED KINGDOM
IMMUNE RESPONSES IN CHICKS AFTER SINGLE OR DUAL VACCINATION WITH LIVE INFECTIOUS BRONCHITIS MASSACHUSETTS AND VARIANT VACCINES: SOME PRELIMINARY FINDINGS GANAPATHY 1 K, ROTHWELL 2 L, LEMIERE 3 S, KAISER
More informationDifferential Diagnosis of Respiratory Disease in Broilers
UD Poultry Health System(Lasher and Allen Labs) Department of Animal & Food Sciences College of Agriculture and Natural Resources University of Delaware Newark, DE 19717-1303 USA Differential Diagnosis
More informationNEWCASTLE KILLED VACCINES IN BROILERS
Issue No.24 / May 2009 T H E B E N E F I T S O F NEWCASTLE KILLED VACCINES IN BROILERS Dr Vincent TURBLIN Deputy Regional Market Manager Poultry CEVA Animal Health Asia Pacific Selangor, Malaysia Newcastle
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Nobilis IB 4-91 lyophilisate for suspension for chickens 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of
More informationC E E Z A D. Rational Development of Influenza Vaccines: NDV-based influenza vaccines for poultry and livestock
C E E Z A D Center of Excellence for Emerging and Zoonotic Animal Diseases A Department of Homeland Security Center of Excellence Rational Development of Influenza Vaccines: NDV-based influenza vaccines
More informationMS-H Vaccine Eyedrop Suspension
MS-H Vaccine Eyedrop Suspension Vaccination against Mycoplasma synoviae using MS-H strain, live temperature sensitive vaccine Dr Peter Cargill BVetMed Cert PMP MRCVS Introduction Review of Mycoplasma synoviae
More informationInfectious Bursal Disease, Immunosuppression and the role of VAXXITEK HVT+ IBD
Research note Infectious Bursal Disease, Immunosuppression and the role of VAXXITEK HVT+ IBD Grogan K. 1 1 Poultry Chicken Scratch, LLC, 30019 Dacula GA United States of America [from Hoerr F.J., 2010,
More informationImproving vaccine titers with Original XPC
As published in Improving vaccine titers with Original XPC By Jonathan Broomhead, Ph.D. Manager, Global Poultry Research and Technical Support Diamond V Vaccination is an important step in protecting animals
More informationAvian Infectious Bronchitis Vaccine, Inactivated
Avian Infectious Bronchitis Vaccine, Inactivated Avian Infectious Bronchitis Vaccine, Inactivated consists of an emulsion or a suspension of one or more serotypes of avian infectious bronchitis virus which
More informationGUMBORO FIELD EXPERIENCES IN SPAIN THINGS WE HAVE LEARNT!
GUMBORO FIELD EXPERIENCES IN SPAIN THINGS WE HAVE LEARNT! JOSÉ LUIS VALLS GARCIA Veterinario consultor avícola Barcelona, 15th March 2016 GUMBORO is an Enzootic disease : Challenge will come immediately
More informationIMMUNOGENICITY OF FORMALDYDE INACTIVATED NEWCASTLE DISEASE VIRUS FIELD ISOLATE IN MATERNAL ANTIBODY FREE CHICKENS
IMMUNOGENICITY OF FORMALDYDE INACTIVATED NEWCASTLE DISEASE VIRUS FIELD ISOLATE IN MATERNAL ANTIBODY FREE CHICKENS Anak Agung Ayu Mirah Adi 1 *, IGusti Agung Arta Putra 2, Nyoman Mantik Astawa 3, I Made
More informationVETERINARY RESEARCH. Alexandra Richard-Mazet 1, Sylvain Goutebroze 1, François-Xavier Le Gros 1, David E Swayne 2 and Michel Bublot 1*
Richard-Mazet et al. Veterinary Research, : VETERINARY RESEARCH RESEARCH Open Access Immunogenicity and efficacy of fowlpox-vectored and inactivated avian influenza vaccines alone or in a prime-boost schedule
More informationINTRODUCTION. J.-H. Roh,,1 M. Kang,,1 B. Wei, R.-H. Yoon, H.-S. Seo, J.-Y. Bahng, J.-T. Kwon, S.-Y. Cha,,1 and H.-K. Jang,2
Efficacy of HVT-IBD vector vaccine compared to attenuated live vaccine using in-ovo vaccination against a Korean very virulent IBDV in commercial broiler chickens J.-H. Roh,,1 M. Kang,,1 B. Wei, R.-H.
More informationLaboratory tools for monitoring and understanding IBDV infection and vaccination
Laboratory tools for monitoring and understanding IBDV infection and vaccination J.J. (Sjaak) de Wit, DVM, PhD, dipl ECPVS GD Deventer, The Netherlands Gumboro-virus (IBDV) Avibirna-virus: segments of
More information2007 : Became Poultry Corporate Marketing Director. Ceva Sante Animale, France
Dr. Sylvain Comte Poultry Corporate Marketing Director Ceva Sante Animale, France Graduated as a Veterinary in 1993 from National Veterinary School of Nantes France Master of science in Physiology and
More informationOriginal Article Phylogenetic Study Based on the Gene of Attachment Protein (G) Avian Metapneumovirus from Broiler Breeder farm in Iran, 2013
Iranian Journal of Virology 2013;7(3): 7-11 2013, Iranian Society of Virology Original Article Phylogenetic Study Based on the Gene of Attachment Protein (G) Avian Metapneumovirus from Broiler Breeder
More informationAviagenBrief. Marek s Disease Control in Broiler Breeders
AviagenBrief January 2018 Marek s Disease Control in Broiler Breeders Author: A. Gregorio Rosales DVM, MS, PhD, DACPV - Poultry Health Consultant Introduction Marek s Disease Virus (MDV), a highly infectious
More informationAvian Influenza. Regional Workshops: Veterinary Discussion. Will Garton
Avian Influenza Regional Workshops: Veterinary Discussion Will Garton What is Avian Influenza? Influenza virus types A B C BIRDS, MAMMALS (including humans, pigs, horses, mink, sea mammals etc) HUMANS
More informationCENSA-IZSVE: OIE TWINNING PROJECT on AVIAN INFLUENZA and NEWCASTLE DISEASE ( ) Marco De Nardi N. Micoli; MS. Beato; C.
CENSA CENSA-IZSVE: OIE TWINNING PROJECT on AVIAN INFLUENZA and NEWCASTLE DISEASE (2008-2010) 2010) Marco De Nardi N. Micoli; MS. Beato; C. Battisti OIE/FAO Reference Laboratory for Newcastle disease and
More informationMYCOPLASMOSIS - A SERIOUS PROBLEM OF POULTRY INDUSTRY
By, Dr. J. L. Vegad Advisor Phoenix Group MYCOPLASMOSIS - A SERIOUS PROBLEM OF POULTRY INDUSTRY Mycoplasmosis, commonly known as chronic respiratory disease of chickens, has existed in our country since
More informationKeeping first class eggs flying high.
Keeping first class eggs flying high. www.msd-animal-health.com Mycoplasma synoviae (MS) in chickens MS IS A GLOBAL CHALLENGE AND OUTBREAKS HAVE BEEN SEEN AROUND THE WORLD SINCE THE 196 S MS starts as
More informationSalmonella Control Programs in the USA
Salmonella Control Programs in the USA Hector Cervantes, DVM, MSc, DACPV, Hon. MAM Senior Manager Poultry Veterinary Services Adjunct Prof. of Avian Medicine College of Veterinary Medicine University of
More informationInfectious Bronchitis: how to maximize cross-protection. GD Animal Health - The Netherlands
Infectious Bronchitis: how to maximize cross-protection GD Animal Health - The Netherlands Infectious Bronchitis: how to maximize cross-protection J.J. (Sjaak) de Wit, DVM, PhD, dipl ECPVS GD Animal Health
More informationResearch Update: Avian Disease & Oncology Lab (ADOL) and SEPRL Endemic Poultry Virus Diseases (EPVD)
Research Update: Avian Disease & Oncology Lab (ADOL) and SEPRL Endemic Poultry Virus Diseases (EPVD) John Dunn, Hans Cheng, Mohammad Heidari, Huanmin Zhang, Taejoong Kim, Stephen Spatz, Qingzhong Yu USDA-ARS-USPNRC
More informationPRESS RELEASE. Libourne, May 29 th, 2013: The signature of a scientific collaboration protocol about avian influenza vaccines between
Libourne, May 29 th, 2013: The signature of a scientific collaboration protocol about avian influenza vaccines between Dr. Marc Prikazsky, Chairman and Chief Executive Officer and Prof. Ren Tao, Vice-Dean
More informationNewcastle disease. in the Czech Republic
Newcastle disease in the Czech Republic Petr Šatrán, Brussels, SCoPAFF 18. 4. 2018 Prevention of Newcastle Disease in the Czech Republic Vaccination against Newcastle disease Mandatory for: Registered
More informationby Dr Thijs van Dijk and Anna-Christina Riebau Marketing Poultry Vaccines, Lohmann Animal Health
Gumboro vaccination a matter of timing ive IBD vaccines are categorised by their break- titre, virulence and Lthrough potential to induce immune suppression, into mild, intermediate and intermediate plus.
More informationENVIRONMENT AND HEALTH
ENVIRONMENT AND HEALTH Infection and Immunity in Broiler Chicken Breeders Vaccinated with a Temperature-Sensitive Mutant of Mycoplasma gallisepticum and Impact on Performance of Offspring E. K. Barbour,*,1
More informationBenefits Beyond Protection Porcine Pleuropneumonia: From A Good Detection To. A Good Protection. Stress: COGLAPIX.
Hatcheries & Broilers Layers & Breeders I s s u e 8 M a r c h 2 9 A s i a P a c i f i c CEVAC TRANSMUNE IBD: CEVAC TRANSMUNE IBD: The Life The Life Cycle Of An Cycle Of An ImmuneComplex Vaccine ImmuneComplex
More informationThe Influence of Different Challenge Doses of Highly Pathogenic Avian Influenza on the Efficacy of Different Avian Influenza Vaccine
American Journal of Microbiology and Biotechnology 2016; 3(3): 18-22 http://www.aascit.org/journal/ajmb ISSN: 2375-3005 The Influence of Different Challenge Doses of Highly Pathogenic Avian Influenza on
More informationCOMPARATIVE EFFICACY OF AVINEW (VG/GA STRAIN) AND BCRDV (F STRAIN) VACCINES AGAINST NEWCASTLE DISEASE IN BROILER CHICKENS
Bangl. J. Vet. Med. (2007). 5 (1 & 2): 19 23 COMPARATIVE EFFICACY OF AVINEW (VG/GA STRAIN) AND BCRDV (F STRAIN) VACCINES AGAINST NEWCASTLE DISEASE IN BROILER CHICKENS M. S. Mahmud 1, M. T. Hossain, P.
More informationBiosecurity and biosafety in the laboratory: Experience of the OIE Reference Laboratory for Avian Influenza
Biosecurity and biosafety in the laboratory: Experience of the OIE Reference Laboratory for Avian Influenza Isabella Monne (DVM, PhD) National OIE/FAO Reference Laboratory for Newcastle Disease and Avian
More informationFALSE LAYERS UPDATE EGG & PULLET FARMERS WORKSHOP 2017 DAN VELDMAN
FALSE LAYERS UPDATE EGG & PULLET FARMERS WORKSHOP 2017 DAN VELDMAN One of these hens is a false layer which one? False Layer Layer DEFINITION False Layer (Poultry) : a hen with the appearance and behavior
More information